Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

Similar articles for PubMed (Select 21947655)

1.

Cost utility of behavioural activation delivered by the non-specialist.

Ekers D, Godfrey C, Gilbody S, Parrott S, Richards DA, Hammond D, Hayes A.

Br J Psychiatry. 2011 Dec;199(6):510-1. doi: 10.1192/bjp.bp.110.090266. Epub 2011 Sep 22.

2.

Behavioural activation delivered by the non-specialist: phase II randomised controlled trial.

Ekers D, Richards D, McMillan D, Bland JM, Gilbody S.

Br J Psychiatry. 2011 Jan;198(1):66-72. doi: 10.1192/bjp.bp.110.079111.

3.

Cost and outcome of behavioural activation versus cognitive behaviour therapy for depression (COBRA): study protocol for a randomised controlled trial.

Rhodes S, Richards DA, Ekers D, McMillan D, Byford S, Farrand PA, Gilbody S, Hollon SD, Kuyken W, Martell C, O'Mahen HA, O'Neill E, Reed N, Taylor RS, Watkins ER, Wright KA.

Trials. 2014 Jan 21;15:29. doi: 10.1186/1745-6215-15-29.

4.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

5.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

6.

Comparative effectiveness and cost-effectiveness of the implantable miniature telescope.

Brown GC, Brown MM, Lieske HB, Lieske PA, Brown KS, Lane SS.

Ophthalmology. 2011 Sep;118(9):1834-43. doi: 10.1016/j.ophtha.2011.02.012. Epub 2011 Jul 2.

PMID:
21723614
7.

The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.

McLoughlin DM, Mogg A, Eranti S, Pluck G, Purvis R, Edwards D, Landau S, Brown R, Rabe-Heskith S, Howard R, Philpot M, Rothwell J, Romeo R, Knapp M.

Health Technol Assess. 2007 Jul;11(24):1-54.

8.

A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.

Peveler R, Kendrick T, Buxton M, Longworth L, Baldwin D, Moore M, Chatwin J, Goddard J, Thornett A, Smith H, Campbell M, Thompson C.

Health Technol Assess. 2005 May;9(16):1-134, iii.

9.

Psychological therapies including dialectical behaviour therapy for borderline personality disorder: a systematic review and preliminary economic evaluation.

Brazier J, Tumur I, Holmes M, Ferriter M, Parry G, Dent-Brown K, Paisley S.

Health Technol Assess. 2006 Sep;10(35):iii, ix-xii, 1-117. Review.

10.

Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling.

Connock M, Stevens C, Fry-Smith A, Jowett S, Fitzmaurice D, Moore D, Song F.

Health Technol Assess. 2007 Oct;11(38):iii-iv, ix-66. Review.

11.

Cost-effectiveness of rehabilitation after an acute coronary event: a randomised controlled trial.

Briffa TG, Eckermann SD, Griffiths AD, Harris PJ, Heath MR, Freedman SB, Donaldson LT, Briffa NK, Keech AC.

Med J Aust. 2005 Nov 7;183(9):450-5.

PMID:
16274344
12.

Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial.

McCrone P, Knapp M, Proudfoot J, Ryden C, Cavanagh K, Shapiro DA, Ilson S, Gray JA, Goldberg D, Mann A, Marks I, Everitt B, Tylee A.

Br J Psychiatry. 2004 Jul;185:55-62.

13.

The cost-effectiveness of testing for hepatitis C in former injecting drug users.

Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, Stein K.

Health Technol Assess. 2006 Sep;10(32):iii-iv, ix-xii, 1-93.

14.

Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling.

Robinson M, Palmer S, Sculpher M, Philips Z, Ginnelly L, Bowens A, Golder S, Alfakih K, Bakhai A, Packham C, Cooper N, Abrams K, Eastwood A, Pearman A, Flather M, Gray D, Hall A.

Health Technol Assess. 2005 Jul;9(27):iii-iv, ix-xi, 1-158. Review.

15.

Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial).

Michaels JA, Campbell WB, Brazier JE, Macintyre JB, Palfreyman SJ, Ratcliffe J, Rigby K.

Health Technol Assess. 2006 Apr;10(13):1-196, iii-iv. Review.

16.

Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation.

Main C, Palmer S, Griffin S, Jones L, Orton V, Sculpher M, Henderson R, Sudlow C, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(40):iii-iv, xv-xvi, 1-141. Review.

18.

Cost-effectiveness of acupuncture care as an adjunct to exercise-based physical therapy for osteoarthritis of the knee.

Whitehurst DG, Bryan S, Hay EM, Thomas E, Young J, Foster NE.

Phys Ther. 2011 May;91(5):630-41. doi: 10.2522/ptj.20100239. Epub 2011 Mar 17.

19.

Cost-effectiveness of treatments for major depression in primary care practice.

Lave JR, Frank RG, Schulberg HC, Kamlet MS.

Arch Gen Psychiatry. 1998 Jul;55(7):645-51.

PMID:
9672056
20.

Cost-effectiveness and safety of epidural steroids in the management of sciatica.

Price C, Arden N, Coglan L, Rogers P.

Health Technol Assess. 2005 Aug;9(33):1-58, iii.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk